Angle (AGL) RNS Announcements

Add to Alert list
Date Time Source Announcement
22 Jun 2022 07:00 AM
RNS
Secured contract from pharma services customer
16 Jun 2022 07:00 AM
RNS
Predicting immunotherapy response in SCLC
14 Jun 2022 07:00 AM
RNS
Potential role of invasive cellular protrusions
30 May 2022 07:00 AM
RNS
Partnership with major United States urology group
27 May 2022 07:00 AM
RNS
Molecular characterisation of CTCs
25 May 2022 04:35 PM
RNS
Price Monitoring Extension
25 May 2022 12:30 PM
RNS
ANGLE receives FDA clearance for Parsortix
20 May 2022 07:00 AM
RNS
Prostate Cancer UK funds new study using Parsortix
28 Apr 2022 07:00 AM
RNS
Preliminary Results
20 Apr 2022 07:00 AM
RNS
Notice of Preliminary Results and Webcast
14 Apr 2022 07:00 AM
RNS
Poster on Parsortix system presented at AACR 2022
01 Apr 2022 07:00 AM
RNS
Identifying drug targets in cancer metastasis
29 Mar 2022 07:00 AM
RNS
Rapid information on patient response to therapies
25 Mar 2022 07:00 AM
RNS
Identifying therapeutic targets in TNBC patients
15 Mar 2022 07:00 AM
RNS
Update on laboratory accreditation
09 Mar 2022 04:41 PM
RNS
Second Price Monitoring Extn
09 Mar 2022 04:36 PM
RNS
Price Monitoring Extension
02 Mar 2022 06:29 PM
RNS
Holding(s) in Company
18 Feb 2022 05:13 PM
RNS
Issue of Equity
21 Jan 2022 07:00 AM
RNS
Potential in immunotherapy treatment selection
17 Jan 2022 07:00 AM
RNS
Concordance of Parsortix with tissue biopsy
13 Jan 2022 07:00 AM
RNS
Update on lab accreditation and ovarian study
10 Jan 2022 07:00 AM
RNS
Insight into drug resistance in NSCLC
22 Dec 2021 06:29 PM
RNS
Issue of Equity
01 Dec 2021 06:11 PM
RNS
Issue of Equity
01 Dec 2021 07:00 AM
RNS
Parsortix in RNA analysis of CTCs as tool in NSCLC
26 Nov 2021 05:33 PM
RNS
Issue of Equity
17 Nov 2021 10:32 AM
RNS
Issue of Equity
15 Nov 2021 07:00 AM
RNS
Issue of LTIP Options and Share Options
15 Nov 2021 07:00 AM
RNS
Appointment of Chief Medical Officer
12 Nov 2021 05:51 PM
RNS
Issue of Equity
12 Nov 2021 07:00 AM
RNS
Participation at Jefferies healthcare conference
11 Nov 2021 07:00 AM
RNS
Parsortix system showcased at NCRI Festival
10 Nov 2021 05:40 PM
RNS
Issue of Equity
02 Nov 2021 07:00 AM
RNS
Change of Adviser
21 Oct 2021 05:25 PM
RNS
Issue of Equity
15 Oct 2021 05:45 PM
RNS
Issue of Equity
30 Sep 2021 04:02 PM
RNS
Issue of Equity
30 Sep 2021 07:00 AM
RNS
Interim Results
27 Sep 2021 07:00 AM
RNS
Parsortix demonstrates ability to isolate CTCs
22 Sep 2021 07:00 AM
RNS
Study shows use of Parsortix to assess PD-L1
20 Sep 2021 07:00 AM
RNS
Parsortix enables gene expression analysis in mPCa
07 Sep 2021 07:00 AM
RNS
Notice of Interim Results and Webcast
24 Aug 2021 07:00 AM
RNS
Director/PDMR Shareholding
09 Aug 2021 07:00 AM
RNS
Study highlights superior performance of Parsortix
06 Aug 2021 01:17 PM
RNS
Issue of Equity
03 Aug 2021 03:13 PM
RNS
Issue of Equity
28 Jul 2021 07:00 AM
RNS
Contract secured for bespoke assay development
09 Jul 2021 07:00 AM
RNS
Harvesting CTCs from brain metastasis patients
07 Jul 2021 06:34 PM
RNS
Director/PDMR Shareholding

ANGLE PLC is a commercially driven specialist medical diagnostic company with pioneering products in cancer diagnostics and foetal health. The Company's product includes Parsortix cell separation system.

Founded in 1994, AGL share price listed on LSE in 2004 under the ticker AGL.

UK 100